2024-07-25T03:06:22.461Z

LOXO-FG3

LOXO-FG3
Solid tumors

An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.

An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Solid tumours

Study Phase

III

Trial registration
GenesisCare Location(s)

GenesisCare North Shore 

GenesisCare North Shore  :::
Principal Investigator(s)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.